Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
BioCryst Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing, and commercializing novel, oral, small-molecule medicines for patients with rare and serious diseases. Their focus areas include hereditary angioedema (HAE) and other complement-mediated diseases, as well as virology. Their flagship product, ORLADEYO® (berotralstat), is an oral, once-daily therapy for preventing HAE attacks. BioCryst's pipeline includes potential treatments for paroxysmal nocturnal hemoglobinuria (PNH), influenza, and other rare conditions, leveraging their expertise in structure-guided drug design.
The Durham headquarters serves as the central hub for executive leadership, research and development (R&D) operations, clinical development, corporate strategy, finance, legal, and administrative functions.
Located within a modern business park, the facility is likely equipped with state-of-the-art laboratory spaces for drug discovery and development, along with contemporary office environments designed to foster collaboration and innovation.
The work culture at BioCryst's headquarters is likely characterized by a strong scientific focus, collaboration, and a patient-centric mission. Employees are driven by the opportunity to make a significant impact on the lives of individuals with rare diseases.
Its location in Research Triangle Park provides access to a rich ecosystem of academic institutions, skilled talent, and other life science companies, fostering innovation and partnerships. It's central to their US operations and global R&D strategy.
BioCryst Pharmaceuticals supports its global operations through its headquarters in Durham, NC, and key international offices in Dublin, Ireland (EMEA hub) and Tokyo, Japan (Asia-Pacific hub). These locations enable the company to conduct global clinical trials, manage regulatory affairs across multiple jurisdictions, and commercialize its approved therapies, such as ORLADEYO®, in North America, Europe, and Asia. Their presence facilitates engagement with local healthcare providers, patient advocacy groups, and regulatory bodies worldwide.
4505 Emperor Blvd, Suite 200
Durham
North Carolina
USA
Address: Block C, Iveagh Court, Harcourt Road, Dublin 2, Ireland
To support the launch and commercialization of ORLADEYO® and future products across the EMEA region, engage with European healthcare systems, and manage regional clinical trial activities.
Address: Toranomon Hills Mori Tower, 1-23-1 Toranomon, Minato-ku, Tokyo 105-6322, Japan
To navigate the Japanese regulatory landscape, conduct clinical trials tailored to the local population, and build a commercial presence to bring therapies like ORLADEYO® to patients in Japan.
Address: Information on a specific large office in New York is not prominently listed, but companies often have smaller, strategic presences or use flexible office spaces for specific functions like investor relations or business development.
Facilitating engagement with the financial community, potential partners, and strategic stakeholders based in the New York metropolitan area.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, BioCryst Pharmaceuticals, Inc.' leadership includes:
BioCryst Pharmaceuticals, Inc. has been backed by several prominent investors over the years, including:
BioCryst Pharmaceuticals has made several strategic appointments and promotions to strengthen its leadership team over the past year, particularly in business development, data insights, and regulatory affairs, reflecting its growth and focus on commercialization and pipeline advancement. No major C-suite departures were prominently announced.
Discover the tools BioCryst Pharmaceuticals, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BioCryst Pharmaceuticals primarily uses the email format combining the first initial and last name. Variations may exist, but this is the most common structure.
[first_initial][last]@biocryst.com
Format
jdoe@biocryst.com
Example
85%
Success rate
BioCryst Pharmaceuticals • May 7, 2024
BioCryst announced its financial results for Q1 2024, highlighting $80.2 million in ORLADEYO net revenue. The company reaffirmed its full-year 2024 ORLADEYO net revenue guidance of $380 million to $400 million and expects continued patient growth....more
BioCryst Pharmaceuticals • April 1, 2024
BioCryst announced that new data on ORLADEYO, including analyses on long-term efficacy, patient-reported outcomes, and real-world evidence, would be presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2024 Annual Meeting....more
BioCryst Pharmaceuticals • February 21, 2024
BioCryst reported its Q4 and full-year 2023 financial results, with ORLADEYO net revenue of $326.6 million for 2023. The company provided its 2024 financial outlook, emphasizing continued growth for ORLADEYO and advancement of its pipeline....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including BioCryst Pharmaceuticals, Inc., are just a search away.